Diagnostic Utility of CD14, CD33, CD123, and MPO Immunostains in Myelomonocytic Neoplasms

被引：0
|
作者：
Rollins-Raval, M. A. [1 ]
Garcia, C. F. [1 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
LABORATORY INVESTIGATION | 2010年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1426
引用
收藏
页码：319A / 319A
页数：1
相关论文
共 50 条
  • [1] Diagnostic Utility of CD14, CD33, CD123, and MPO Immunostains in Myelomonocytic Neoplasms
    Rollins-Raval, M. A.
    Garcia, C. F.
    MODERN PATHOLOGY, 2010, 23 : 319A - 319A
  • [2] The value of immunohistochemistry for CD14, CD123, CD33, myeloperoxidase and CD68R in the diagnosis of acute and chronic myelomonocytic leukaemias
    Rollins-Raval, Marian A.
    Roth, Christine G.
    HISTOPATHOLOGY, 2012, 60 (06) : 933 - 942
  • [3] Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms
    Nakase, K
    Kita, K
    Shiku, H
    Tanaka, I
    Nasu, K
    Dohy, H
    Kyo, T
    Tsutani, H
    Kamada, N
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1996, 105 (06) : 761 - 768
  • [4] Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia
    Ehninger, A.
    Kramer, M.
    Roellig, C.
    Thiede, C.
    Bornhaeuser, M.
    von Bonin, M.
    Wermke, M.
    Feldmann, A.
    Bachmann, M.
    Ehninger, G.
    Oelschlaegel, U.
    BLOOD CANCER JOURNAL, 2014, 4 : e218 - e218
  • [5] Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia
    A Ehninger
    M Kramer
    C Röllig
    C Thiede
    M Bornhäuser
    M von Bonin
    M Wermke
    A Feldmann
    M Bachmann
    G Ehninger
    U Oelschlägel
    Blood Cancer Journal, 2014, 4 : e218 - e218
  • [6] Hypertrophic lupus erythematosus: the diagnostic utility of CD123 staining
    Ko, Christine J.
    Srivastava, Bhaskar
    Braverman, Irwin
    Antaya, Richard J.
    McNiff, Jennifer M.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2011, 38 (11) : 889 - 892
  • [7] ACUTE MYELOID-LEUKEMIA WITH AN UNUSUAL PHENOTYPE - MYELOPEROXIDASE (+), CD13(-), CD14(-) AND CD33(-)
    SESHI, B
    KASHYAP, A
    BENNETT, JM
    BRITISH JOURNAL OF HAEMATOLOGY, 1992, 81 (03) : 374 - 377
  • [8] Loop33 x 123 CAR-T targeting CD33 and CD123 against immune escape in acute myeloid leukemia
    Ma, Haotian
    Yan, Zhifeng
    Gu, Runxia
    Xu, Yingxi
    Qiu, Shaowei
    Xing, Haiyan
    Tang, Kejing
    Tian, Zheng
    Rao, Qing
    Wang, Min
    Wang, Jianxiang
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 74 (01)
  • [9] Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia
    Boucher, Justin C.
    Shrestha, Bishwas
    Vishwasrao, Paresh
    Leick, Mark
    Cervantes, Estelle V.
    Ghafoor, Tayyebb
    Reid, Kayla
    Spitler, Kristen
    Yu, Bin
    Betts, Brian C.
    Guevara-Patino, Jose A.
    Maus, Marcela V.
    Davila, Marco L.
    MOLECULAR THERAPY ONCOLYTICS, 2023, 31
  • [10] Integrating CRISPR-Cas12a with Aptamer as a Logic Gate Biosensing Platform for the Detection of CD33 and CD123
    Yang, Xinyi
    Shi, Xiaolong
    Lv, Chenyu
    Liu, Wenbin
    Zhang, Fengyue
    Liu, Bo
    ACS OMEGA, 2025, 10 (13): : 13634 - 13644
12345